CALC

CALC Announces 2023 Annual Results

Retrieved on: 
Tuesday, March 19, 2024

Shareholders Profit Surged by Four Times

Key Points: 
  • Shareholders Profit Surged by Four Times
    HONG KONG, Mar 19, 2024 - (ACN Newswire) - China Aircraft Leasing Group Holdings Limited ("CALC" or the "Company", together with its subsidiaries, the "Group"; SEHK stock code: 01848), a full value chain aircraft solutions provider for the global aviation industry, is pleased to announce its annual results for the year ended 31 December 2023 (the "Review Year").
  • Together with the 2023 interim dividend of HK$0.15 per share already paid, total dividend payout for the year 2023 amounted to HK$0.30 (2022: HK$0.30 per share).
  • The Company has resumed its scrip dividend scheme for the final dividend for 2023.
  • As at 31 December 2023, the Group had cash and cash equivalents amounting to HK$5,300 million up 49.1% year-on-year.

Zeevo Group’s Client Success Team Gets Boost With New Member Megan King

Retrieved on: 
Tuesday, April 9, 2024

Zeevo Group LLC ("Zeevo"), an operations, finance, and information technology consulting services firm, welcomed Megan King as a new member of its Client Success Team.

Key Points: 
  • Zeevo Group LLC ("Zeevo"), an operations, finance, and information technology consulting services firm, welcomed Megan King as a new member of its Client Success Team.
  • "With her extensive network of relationships with aircraft leasing companies, airlines, manufacturers, and maintenance service providers, she is the perfect fit for our Client Success Team."
  • King joins Zeevo from Smithbucklin following a ten-year-plus tenure at the association management company that delivers management and specialized services to trade and professional associations.
  • "I am thrilled and honored to be joining the elite team at Zeevo," said Megan King, a newly appointed consultant of Zeevo Group.

CALC (1848.HK) Announces Tender Offer to Purchase Outstanding USD Bonds

Retrieved on: 
Wednesday, September 6, 2023

HONG KONG, Sept. 6, 2023 /PRNewswire/ -- China Aircraft Leasing Group Holdings Limited ("CALC" or the "Company", together with its subsidiaries, the "Group"; HKEX stock code: 01848), released announcement detailing the commencement of a tender offer to purchase for cash the outstanding amount of two USD bonds due 2024 (the "Offers").

Key Points: 
  • HONG KONG, Sept. 6, 2023 /PRNewswire/ -- China Aircraft Leasing Group Holdings Limited ("CALC" or the "Company", together with its subsidiaries, the "Group"; HKEX stock code: 01848), released announcement detailing the commencement of a tender offer to purchase for cash the outstanding amount of two USD bonds due 2024 (the "Offers").
  • The Offers are being made as part of the Group's proactive approach in debt management aiming to enhance its international credit rating.
  • The Offers are made on the terms and subject to the conditions contained in the tender offer memorandum dated 6 September 2023.
  • The two USD bonds to be purchased under the tender offer memorandum include the US$200 million 5.50% Guaranteed Bonds (Stock Code: 05391.HK) due March 2024 and US$100 million 4.85% Guaranteed Notes (Stock Code: 40972.HK) due December 2024 with purchase price of US$982 and US$935 per US$1,000 principal amount, respectively.

China Everbright Limited Announces 2023 Interim Results, Realises Turnaround of Loss to Profit

Retrieved on: 
Friday, August 25, 2023

HONG KONG, Aug 25, 2023 - (ACN Newswire) - On 25 August 2023, China Everbright Limited ("CEL" or the "Company", stock code: 165.HK) announced its interim results for the six months ended 30 June 2023 ("the reporting period").

Key Points: 
  • HONG KONG, Aug 25, 2023 - (ACN Newswire) - On 25 August 2023, China Everbright Limited ("CEL" or the "Company", stock code: 165.HK) announced its interim results for the six months ended 30 June 2023 ("the reporting period").
  • -- The overall operating revenue was HK$1.54 billion, representing a steady increase in overall operating results
    -- Profit attributable to shareholders of the Company was HK$313 million, realising a turnaround from loss to profit.
  • To share the fruits of the Company's development with shareholders and investors, the Board of Directors declared interim dividend of HK$0.15 per share for 2023.
  • Mr. Zhang Mingao, Executive Director and President of China Everbright Limited, said: "In the first half of 2023, there was steady recovery in the Chinese economy and a significant upturn.

Pratt & Whitney GTF™ Engines Surpass 800 Orders and Commitments in 2023

Retrieved on: 
Wednesday, June 21, 2023

PARIS, June 21, 2023 /PRNewswire/ -- PARIS AIR SHOW -- Pratt & Whitney, an RTX business, has announced more than 800 GTF engine orders and commitments, including spare engines, since the beginning of 2023.

Key Points: 
  • PARIS, June 21, 2023 /PRNewswire/ -- PARIS AIR SHOW -- Pratt & Whitney, an RTX business, has announced more than 800 GTF engine orders and commitments, including spare engines, since the beginning of 2023.
  • Airlines and lessors who have announced orders include Azorra , CALC, Carlyle Aviation Partners, Binter , Croatia Airlines , LATAM Airlines , Qantas Airways , United Airlines and Volaris .
  • In total, more than 10,000 GTF engine orders and commitments have been placed by more than 90 customers worldwide.
  • "The GTF engine offers unmatched economic and environmental benefits, and these latest orders are a testament to the value it delivers to customers," said Rick Deurloo, president of Commercial Engines at Pratt & Whitney.

CalciMedica Announces Relisting on Nasdaq

Retrieved on: 
Monday, June 12, 2023

LA JOLLA, Calif., June 12, 2023 (GLOBE NEWSWIRE) -- CalciMedica Inc. (“CalciMedica”) (OTCQB: CALC), a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need, today announced that The Nasdaq Stock Market LLC has approved CalciMedica’s application for the relisting of the Company’s common stock on the Nasdaq Capital Market.

Key Points: 
  • LA JOLLA, Calif., June 12, 2023 (GLOBE NEWSWIRE) -- CalciMedica Inc. (“CalciMedica”) (OTCQB: CALC), a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need, today announced that The Nasdaq Stock Market LLC has approved CalciMedica’s application for the relisting of the Company’s common stock on the Nasdaq Capital Market.
  • The Company’s common stock is expected to commence trading on the Nasdaq Capital Market at the opening of trading on Wednesday, June 14, 2023, under the ticker symbol “CALC”.
  • CalciMedica’s common stock will continue to trade on the OTCQB until market close on the date before listing on the Nasdaq Stock Market under the ticker symbol "CALC".
  • “We are pleased that we are regaining our listing on Nasdaq, an achievement that benefits shareholders and the CalciMedica organization at large,” said Rachel Leheny, Ph.D., Chief Executive Officer of CalciMedica.

Notable Labs Presents Data Demonstrating PPMP’s Potential to Identify Novel Drug Combinations in JMML at the 2023 EHA Hybrid Congress

Retrieved on: 
Friday, June 9, 2023

FOSTER CITY, Calif., June 09, 2023 (GLOBE NEWSWIRE) -- Notable Labs, Inc. (“Notable”), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, today presented data from an ex vivo study demonstrating the potential for its Predictive Precision Medicine Platform (PPMP) to identify more active investigational pre-hematopoietic stem cell therapy (pre-HCST) regimens for the treatment of juvenile myelomonocytic leukemia (JMML) at the European Hematology Association (EHA) Hybrid Congress being held in Frankfurt, Germany on June 8 – 15, 2023.

Key Points: 
  • Of 130 drug combinations, 27 were shown to be more active in killing leukemic cells ex vivo than compounds represented in these combinations on their own.
  • These results highlight PPMP as a potential tool for identifying superior drug combinations for patients with high medical needs, including with JMML.
  • Abstract title: Tretinoin and calcitriol enhance treatment regimens for juvenile myelomonocytic leukemia in ex vivo drug sensitivity assays.
  • Additional meeting information can be found on the 2023 EHA Congress website, https://ehaweb.org/congress/eha2023-hybrid-congress/eha2023/ .

CALC (1848.HK)'s subsidiary CALC (TJ) completes first low-carbon transition corporate bond issue in 2023, recording subscription application of nearly 3 times

Retrieved on: 
Tuesday, June 6, 2023

It attracted a subscription application of 2.83 times, and its coupon rate hit a new low of 3.85% among CALC (TJ)'s bonds with the same term.

Key Points: 
  • It attracted a subscription application of 2.83 times, and its coupon rate hit a new low of 3.85% among CALC (TJ)'s bonds with the same term.
  • As the first low-carbon transition corporate bond issued by CALC (TJ) on the Shanghai Stock Exchange, the subscription scale and the number of participating investors of this bond issuance have reached a new height among bonds issued by CALC (TJ) with the same term.
  • It lays a solid foundation for CALC (TJ)'s low-carbon transition, and help further promote the sustainable development of the civil aviation industry.
  • This issuance is also our second attempt in the capital market following the successful issuance of the first low-carbon transition bond in October 2022.